Øresund Pharma ApS: Financial statements 2022
CVR: 39492059
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Øresund Pharma ApS (CVR 39492059) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 17,238,144 and a net result of DKK 4,302,384 compared with DKK 281,255 the year before. That is an increase of 136.9% compared with the year before. Equity in the 2022 report amounted to DKK 7,692,429. The solvency ratio was 24.9%. The company had 6 employees in the financial year.
- Gross Profit
- DKK 17,238,144
- Profit/Loss
- DKK 4,302,384
- Equity
- DKK 7,692,429
- Total Assets
- DKK 30,950,709
- Employees
- 6
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 17.2 mio. | 4.3 mio. | 7.7 mio. | 6 |
| 2021 | - | 7.3 mio. | 281 t. | 3.4 mio. | 5 |
| 2020 | - | 2.8 mio. | -86 t. | 3.1 mio. | 4 |
| 2019 | - | 4.9 mio. | 2.6 mio. | 2.7 mio. | 3 |
Official annual report
Keep an eye on Øresund Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Øresund Pharma ApS has published its annual report for 2021. Gross profit came to DKK 7,275,387, and the net result was DKK 281,255.
About Øresund Pharma ApS
Øresund Pharma ApS is a Danish company of the type Anpartsselskab based in Nordhavn, founded in 2018. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Øresund Pharma IVS. The management consists of Patrick Halborg Cohn and Svend Aage Johansen. The company is owned by Machpali ApS and ESH Holding 2019 ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 39,702,011 and a net result of DKK 6,466,876 compared with DKK 13,707,320 the year before. Equity in the 2025 report amounted to DKK 44,617,595.